Article Details
Retrieved on: 2023-12-08 23:10:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Casgevy, the first CRISPR therapy approved by the FDA, will cost $2.2 million, while a competing genetic medicine also cleared Friday is priced at ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here